Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy
NCT02638233
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis C
Interventions
DRUG:
Sofosbuvir 400mg / Ledipasvir 90 mg (FDC)
Sponsor
Wilhelminenspital Vienna
Collaborators
[object Object]